mTOR Kinase Inhibitor II, WYE-354

CAS : 1062169-56-5

Ref. 3D-MSB16956

Informations sur le produit

• Nom: mTOR Kinase Inhibitor II, WYE-354
• Synonymes: 4-[6-[4-[(Methoxycarbonyl)amino]phenyl]-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinecarboxylic acid methyl ester, Methyl 4-[6-{4-[(methoxycarbonyl)amino]phenyl}-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinecarboxylate
• CAS: 1062169-56-5

Description

WYE-354 is a pyrimidine compound that inhibits mTOR kinase, the target of rapamycin. It has been shown to inhibit the production of pro-angiogenic factors and to be an immunosuppressant in vitro and in vivo. WYE-354 also reduces senescent cells, metabolic disorders, and prostate cancer cell growth. The drug increases autophagy levels and induces autophagy in vitro. This drug has not been tested on infectious diseases or autoimmune diseases as of yet.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 495.53 g/mol
• Formule: C₂₄H₂₉N₇O₅
• Degré de pureté: Min. 95%